Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (988,320)	$ (857,810)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation	272,615	720,458
Common stock and stock option based compensation for employees and board of directors	407,231	1,135,048
Net gain on divestiture of subsidiaries	(1,397,066)	(1,000,000)
Reserve on note received in connection with divestiture of subsidiaries	1,500,000	1,000,000
Gain on office lease termination	(34,660)
Accrued non cash performance bonus fair value adjustment		(551,234)
Acquisition contingent consideration fair value adjustment	61,480	(4,025,544)
Impairment of intangible assets		901,204
Issuance of common stock to vendors		73,282
Adjustment to operating lease right-of-use assets and liabilities	(41,787)	(89,376)
Changes in operating assets and liabilities:
Accounts receivable	(668,847)	208,052
Deferred costs/contract assets	(52,003)	81,560
Loans receivable	(40,900)
Prepaid expenses and other current assets	99,757	(99,231)
Other assets	5,349	(1,507)
Accounts payable	114,108	(180,077)
Accrued liabilities	295,521	(343,474)
Deferred revenue/contract liabilities	214,369	(329,531)
Net cash used in operating activities	(253,153)	(3,358,180)
Cash flow from investing activities:
Purchase of leasehold improvements and equipment	(26,406)	(8,751)
Net cash used in investing activities	(26,406)	(8,751)
Cash flows provided by financing activities:
Proceeds from securities purchase agreement, net	6,785,552	2,968,501
Proceeds from exercise of warrants	175,000
Issuance of note receivable	(84,000)
Cash provided by financing activities	6,876,552	2,968,501
Net change in cash and cash equivalents	6,596,993	(398,430)
Cash and cash equivalents, beginning of year	1,848,295	5,619,083
Cash and cash equivalents, end of period	8,445,288	5,220,653
Non-cash Investing and Financing activities:
Issuance of common stock for satisfaction of contingent liability		127,145
Issuance of common stock for non cash performance bonus		127,145
Lease liabilities arising from right-of-use assets	$ 20,344	$ 113,182